Budget Amount *help |
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2019: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2018: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
Fiscal Year 2017: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Outline of Final Research Achievements |
We crossed Alb-Cre mouse, LSL-Kras G12D mouse and LSL-p53 R172H mouse to generate mutant Kras/p53 expressing mouse. We further introduced Keap1 floxed background into this mouse, leading to the constitutive activation of Nrf2. As a result, addition of Keap1 deletion promoted cholangiocarcinoma development, with increased expression of Nrf2 target genes.
|